Forskolin [66575-29-9]
Cat# HY-15371-10mg
Size : 10mg
Brand : MedChemExpress
Description |
Forskolin (Coleonol) is a potent adenylate cyclase activator with an IC50 of 41 nM and an EC50 of 0.5 μM for type I adenylyl cyclase[1]. Forskolin is also an inducer of intracellular cAMP formation[2]. Forskolin induces differentiation of various cell types and activates pregnane X receptor (PXR) and FXR[3]. Forskolin exerts a inotropic effect on the heart, and has platelet antiaggregatory and antihypertensive actions. Forskolin also induces autophagy[4][5]. |
IC50 & Target | ||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cellular Effect |
|
|||||||||||||||||||||||||||||||||||||||||||||
In Vitro |
Forskolin (Coleonol) is also a potent exosome biogenesis and/or secretion activator in prostate cancer (PC) cells[8]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
|||||||||||||||||||||||||||||||||||||||||||||
In Vivo |
The Forskolin (Coleonol)-treated Mrp4-/- mice shows an increased number of Ki67-positive and cleaved caspase 3-positive ECs, a significant decrease in the amount of pericyte coverage, and a reduced number of empty sleeves. In pups exposed to hyperoxia (75% oxygen) from P7 to P12, the Mrp4-/- mice shows a significant increase in the unvascularized retinal area[2]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
|||||||||||||||||||||||||||||||||||||||||||||
Molecular Weight |
410.50 |
|||||||||||||||||||||||||||||||||||||||||||||
Formula |
C22H34O7 |
|||||||||||||||||||||||||||||||||||||||||||||
CAS No. | ||||||||||||||||||||||||||||||||||||||||||||||
Appearance |
Solid |
|||||||||||||||||||||||||||||||||||||||||||||
Color |
White to off-white |
|||||||||||||||||||||||||||||||||||||||||||||
SMILES |
O=C1[C@@]2(O)[C@]([C@@H](OC(C)=O)[C@@H](O)[C@@]3(01)C(C)(C)CC[C@H](O)[C@@]32C)(C)O[C@@](C)(C=C)C1 |
|||||||||||||||||||||||||||||||||||||||||||||
Structure Classification | ||||||||||||||||||||||||||||||||||||||||||||||
Initial Source | ||||||||||||||||||||||||||||||||||||||||||||||
Shipping | Room temperature in continental US; may vary elsewhere. |
|||||||||||||||||||||||||||||||||||||||||||||
Storage |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
|||||||||||||||||||||||||||||||||||||||||||||
Solvent & Solubility |
In Vitro:
DMSO : 100 mg/mL (243.61 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles. Select the appropriate dissolution method based on your experimental animal and administration route.
For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
|
|||||||||||||||||||||||||||||||||||||||||||||
Purity & Documentation | ||||||||||||||||||||||||||||||||||||||||||||||
References |
|